APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
Clinical trial NCT03165994 · COMPLETED
Trial details
- NCT number
- NCT03165994
- Sponsor
- Apexigen America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-06
- Primary completion
- 2022-11-10
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.